News
-
-
PRESS RELEASE
Teva becomes strategic commercialization partner for Formycon’s biosimilar candidate FYB203 (Eylea®/ aflibercept) in major parts of Europe and Israel
Teva partners with Formycon for commercialization of biosimilar FYB203 (Eylea®) in Europe and Israel, aiming to expand access to innovative medicines -
REGULATED PRESS RELEASE
bioMérieux strengthens its point of care presence with the acquisition of the immunoassay start-up SpinChip
bioMérieux strengthens its point of care presence with the acquisition of the immunoassay start-up SpinChip. The innovative diagnostics platform aims to revolutionize MI diagnosis and improve patient outcomes -
REGULATED PRESS RELEASE
bioMérieux renforce sa présence sur le marché du diagnostic délocalisé (« Point of Care ») avec l'acquisition de SpinChip Diagnostics, une start-up spécialisée dans les tests immunoessais au plus près du patient
bioMérieux renforce sa présence sur le marché du diagnostic délocalisé avec l'acquisition de SpinChip Diagnostics, spécialisée dans les immunoessais Point of Care -
PRESS RELEASE
Critical infrastructure protection with automated people screening from dormakaba and Rohde & Schwarz
dormakaba and Rohde & Schwarz partner to offer innovative APS solution for critical infrastructure protection, increasing security and efficiency. Global pilot projects underway in the USA, Singapore, and the Netherlands -
-
-
-
-
